by Sue Robbins | May 27, 2020 | Migraine
Surgical decompression of supraorbital and supratrochlear nerves may aid migraineurs experiencing moderate to severe chronic frontal migraine who do not respond to medications, according to a study published in Plastic and Reconstructive Surgery (PRS) Global Open....
by Sue Robbins | May 22, 2020 | Migraine
Insufficient response to triptans is associated with poor health-related quality of life (HRQoL) and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain....
by Sue Robbins | May 18, 2020 | Migraine
The FDA has approved Dr. Reddy’s Laboratories’ celecoxib oral solution (Elyxyb) for the treatment of acute migraine in adults with or without aura. Notably, the non-steroidal anti-inflammatory drug (NSAID) was given the go-ahead with a boxed warning related to a risk...
by Sue Robbins | Apr 30, 2020 | Migraine
There are a variety of triggers for the millions of migraine sufferers in the world but stress is one of the biggest. According to the American Headache Society, 80% of migraine sufferers report that stress is a trigger. And the American Migraine...
by Sue Robbins | Apr 27, 2020 | Migraine
Despite significant burden and symptoms, many individuals with migraine have never used acute prescription pain medication to treat the condition, according to study results published in Mayo Clinic Proceedings. The Chronic Migraine Epidemiology and Outcomes study, an...
